Interleukin-1 gene polymorphisms and long-term stability following guided tissue regeneration therapy
about
The association of the composite IL-1 genotype with periodontitis progression and/or treatment outcomes: a systematic reviewLong-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. I. Class II furcations.A critical assessment of interleukin-1 (IL-1) genotyping when used in a genetic susceptibility test for severe chronic periodontitis.Finding genetic risk factors for periodontal diseases: is the climb worth the view?Diagnosis of periodontal diseases.Genes and gene polymorphisms associated with periodontal disease.Guided tissue regeneration for the treatment of periodontal intrabony and furcation defects. A systematic review.Are selected IL-1 polymorphisms and selected subgingival microorganisms significantly associated to periodontitis in type 2 diabetes patients? a clinical study.Informational paper: implications of genetic technology for the management of periodontal diseases.Effect of genetic variability on the inflammatory response to periodontal infection.Analytical epidemiology of periodontitis.Disease progression: identification of high-risk groups and individuals for periodontitis.The genetic basis of periodontitis.Gene polymorphisms in periodontal health and disease.Association of IL-8 (-251 a/t) gene polymorphism with clinical parameters and chronic periodontitis.Long-term periodontal tissue outcome in regenerated infrabony and furcation defects: a systematic review.Association between susceptible genotypes to periodontitis and clinical outcomes of periodontal regenerative therapy: A systematic review.Radiographic defect depth and width for prognosis and description of periodontal healing of infrabony defects.Stability of clinical and radiographic results after guided tissue regeneration in infrabony defects.Long-term results of guided tissue regeneration therapy in the treatment of class II furcation defects: a randomized clinical trial.Enamel matrix derivative in propylene glycol alginate for treatment of infrabony defects with or without systemic doxycycline: 12- and 24-month results.The efficacy of host response modulation therapy (omega-3 plus low-dose aspirin) as an adjunctive treatment of chronic periodontitis (clinical and biochemical study).Site-level progression of periodontal disease during a follow-up period.Early colonization of non-submerged dental implants in patients with a history of advanced aggressive periodontitis.Retrospective evaluation of the influence of the interleukin-1 genotype on radiographic bone levels in treated periodontal patients over 10 years.Long-Term Stability After Regenerative Treatment of Infrabony Defects: A Retrospective Case Series.Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.Radiographic parameters for prognosis of periodontal healing of infrabony defects: two different definitions of defect depth.Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. II. A case series of infrabony defects.Effect of interleukin-1 gene polymorphism in a periodontally healthy Hispanic population treated with mucogingival surgery.Re: A critical assessment of interleukin-1 (IL-1) genotyping when used in a genetic susceptibility test for severe chronic periodontitis. Greenstein G, Hart TC (2002;73:231-247).
P2860
Q28294327-3E57FC23-982B-469D-97E4-D880A0B8E4E2Q32038514-D378FFB3-D86E-450A-A9C4-0EBC2780199CQ34564594-0B657008-6217-479B-8846-239ADDAFBFD0Q34866506-D2DC2E5D-F79D-49DD-8ECE-B44925D90635Q35545604-ABDC7AAF-0DC9-4E4A-B95B-2F8327AFE773Q35600726-C96BD02B-2D74-47B1-82B1-6A55DAC28F35Q35670372-37D09B77-854B-4310-8A4A-97210338DBBBQ35843998-D129C093-607B-46FD-B37A-EC88FC8D0204Q36130298-F99EEC96-9037-4E62-9509-FE4D1616B3A6Q36243400-04879A8C-C2B7-48D5-B75A-E77A299C95F6Q36243411-6F3E6D18-E2A1-4F41-B5AF-C2F5CF9CBF61Q36243423-4A03E40A-E383-44D1-AEEE-A4ACA772A0ACQ36245799-00E86C2F-6C07-47B3-9D74-4D3D3D7D7DACQ36362691-56EA8AD7-78DB-4CD9-954A-6D2E768BFB24Q37419832-C0A88F38-521E-4639-B57B-4CF56FB06BE7Q38257895-091471E4-D432-4266-9FF0-08D76D31651AQ38762149-5AE01157-2682-47CC-B2E7-53D2C4EA04FEQ39591699-CDB61C87-856C-46EF-A292-7D21482FE093Q39780196-73BBF426-8D3D-4FDD-AAEF-97748869B84FQ44320246-23A60FEF-E604-44B8-B20B-10F527DC0016Q44523776-EB0693A4-937D-4568-AFDD-C14F662FC8C7Q46460137-6A2A8621-FCB6-4831-87D5-C73FE09E58E1Q47108578-43710346-C6A1-4EA7-844D-CE9A847BD92AQ49092653-0CEEEA60-E747-4508-9D10-6799B9FF8C14Q49192868-DEFE0623-F84D-41F7-8EAD-132AF1F2E04CQ51063796-A02F796C-FAD0-4638-8EEA-3C1A289F40C0Q51110568-2E82A318-83D0-49FB-AAD8-B9F032DF578EQ51688049-AADCDEC9-F89C-41B5-9E81-B626E45BF93EQ52041218-392CD873-1DAD-4725-BB84-59F1C0EAEC86Q52044662-81971328-7A03-4BC0-B9B6-4D468E084B59Q52947768-D1CF0516-FDDE-41E1-B685-765EAA6D9169
P2860
Interleukin-1 gene polymorphisms and long-term stability following guided tissue regeneration therapy
description
article
@en
im April 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2000
@uk
name
Interleukin-1 gene polymorphis ...... ed tissue regeneration therapy
@en
Interleukin-1 gene polymorphis ...... ed tissue regeneration therapy
@nl
type
label
Interleukin-1 gene polymorphis ...... ed tissue regeneration therapy
@en
Interleukin-1 gene polymorphis ...... ed tissue regeneration therapy
@nl
prefLabel
Interleukin-1 gene polymorphis ...... ed tissue regeneration therapy
@en
Interleukin-1 gene polymorphis ...... ed tissue regeneration therapy
@nl
P2860
P1476
Interleukin-1 gene polymorphis ...... ed tissue regeneration therapy
@en
P2093
G Zucchelli
M De Sanctis
P2860
P304
P356
10.1902/JOP.2000.71.4.606
P407
P577
2000-04-01T00:00:00Z